Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth V Christensen

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Journal of Molecular Neuroscience : MN|May 25, 2012
Glucocorticoid receptor and myocyte enhancer factor 2 cooperate to regulate the expression of c-JUN in a neuronal contextNiels Speksnijder, Kenneth V Christensen, Michael Didriksen, et al.
Brain Research|January 30, 2002
Correlation of the expression of kainate receptor subtypes to responses evoked in cultured cortical and spinal cord neuronesWei-Min Dai, Kenneth V Christensen, Jan Egebjerg, et al.
BMC Neuroscience|January 29, 2010
Levetiracetam attenuates hippocampal expression of synaptic plasticity-related immediate early and late response genes in amygdala-kindled ratsKenneth V Christensen, Henrik Leffers, William P Watson, et al.
Journal of Strength and Conditioning Research|November 1, 2013
Preexercise energy drink consumption does not improve endurance cycling performance but increases lactate, monocyte, and interleukin-6 responseMelody D Phillips, Kelyn S Rola, Kenneth V Christensen, et al.
Protein Expression and Purification|January 16, 2010
Over-expression, purification and characterization of an Asc-1 homologue from Gloeobacter violaceusXiaole Wang, Helle Hald, Heidi A Ernst, et al.
Scientific Reports|September 2, 2017
Selective LRRK2 kinase inhibition reduces phosphorylation of endogenous Rab10 and Rab12 in human peripheral mononuclear blood cellsKenneth Thirstrup, Justus C Dächsel, Felix S Oppermann, et al.
Human Molecular Genetics|April 11, 2014
Abnormal visual gain control in a Parkinson's disease modelFarinaz Afsari, Kenneth V Christensen, Garrick Paul Smith, et al.
Neuropharmacology|May 6, 2008
Recruitment of beta-arrestin2 to the dopamine D2 receptor: insights into anti-psychotic and anti-parkinsonian drug receptor signalingIb V Klewe, Søren M Nielsen, Louise Tarpø, et al.
Translational Psychiatry|December 1, 2017
A mouse model of the schizophrenia-associated 1q21.1 microdeletion syndrome exhibits altered mesolimbic dopamine transmissionJacob Nielsen, Kim Fejgin, Florence Sotty, et al.
Journal of Medicinal Chemistry|June 29, 2021
Design and Synthesis of Pyrrolo[2,3-<i>d</i>]pyrimidine-Derived Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors Using a Checkpoint Kinase 1 (CHK1)-Derived Crystallographic SurrogateDouglas S Williamson, Garrick P Smith, Gitte K Mikkelsen, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Journal of Molecular Neuroscience : MN|May 25, 2012
Glucocorticoid receptor and myocyte enhancer factor 2 cooperate to regulate the expression of c-JUN in a neuronal contextNiels Speksnijder, Kenneth V Christensen, Michael Didriksen, et al.
Brain Research|January 30, 2002
Correlation of the expression of kainate receptor subtypes to responses evoked in cultured cortical and spinal cord neuronesWei-Min Dai, Kenneth V Christensen, Jan Egebjerg, et al.
BMC Neuroscience|January 29, 2010
Levetiracetam attenuates hippocampal expression of synaptic plasticity-related immediate early and late response genes in amygdala-kindled ratsKenneth V Christensen, Henrik Leffers, William P Watson, et al.
Journal of Strength and Conditioning Research|November 1, 2013
Preexercise energy drink consumption does not improve endurance cycling performance but increases lactate, monocyte, and interleukin-6 responseMelody D Phillips, Kelyn S Rola, Kenneth V Christensen, et al.
Protein Expression and Purification|January 16, 2010
Over-expression, purification and characterization of an Asc-1 homologue from Gloeobacter violaceusXiaole Wang, Helle Hald, Heidi A Ernst, et al.
Scientific Reports|September 2, 2017
Selective LRRK2 kinase inhibition reduces phosphorylation of endogenous Rab10 and Rab12 in human peripheral mononuclear blood cellsKenneth Thirstrup, Justus C Dächsel, Felix S Oppermann, et al.
Human Molecular Genetics|April 11, 2014
Abnormal visual gain control in a Parkinson's disease modelFarinaz Afsari, Kenneth V Christensen, Garrick Paul Smith, et al.
Neuropharmacology|May 6, 2008
Recruitment of beta-arrestin2 to the dopamine D2 receptor: insights into anti-psychotic and anti-parkinsonian drug receptor signalingIb V Klewe, Søren M Nielsen, Louise Tarpø, et al.
Translational Psychiatry|December 1, 2017
A mouse model of the schizophrenia-associated 1q21.1 microdeletion syndrome exhibits altered mesolimbic dopamine transmissionJacob Nielsen, Kim Fejgin, Florence Sotty, et al.
Journal of Medicinal Chemistry|June 29, 2021
Design and Synthesis of Pyrrolo[2,3-<i>d</i>]pyrimidine-Derived Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors Using a Checkpoint Kinase 1 (CHK1)-Derived Crystallographic SurrogateDouglas S Williamson, Garrick P Smith, Gitte K Mikkelsen, et al.
Pageof 2